Resources
About Us
Meticulous Research®—a leading market research company, published a research report titled ‘South East Asia IVD Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics, Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology, Diabetes), Diagnostic Approach (Lab, POC) - Forecast to 2030.
According to this latest publication from Meticulous Research®, the South East Asia IVD market is expected to grow at a CAGR of 7% from 2024 to reach $4.11 billion by 2030. The growth of this market is driven by the high prevalence of infectious diseases and high risk of emerging infections, high burden of chronic diseases, and growing focus on strengthening the healthcare industry in the region. Additionally, growing awareness regarding early disease diagnosis and growing medical tourism in the region are expected to create growth opportunities for the stakeholders in this market. However, the large import of tests and instruments and limited local manufacturing facilities restrain the growth of this market. Poor healthcare access in remote populations is a major challenge to market growth.
Key Players
The key players operating in the South East Asia IVD market are Abbott Laboratories (U.S.), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), and Sysmex Corporation. (U.S.).
South East Asia IVD Market: Future Outlook
The South East Asia IVD market is segmented by offering (regents & kits, instruments/systems, and software & services), technology (molecular diagnostics, point-of-care (POC) diagnostics [lateral flow assays/rapid tests, other POC diagnostics] immunoassay/immunochemistry [Enzyme-linked Immunosorbent Assays (ELISA), Enzyme-linked Immunospot Assays (ELISPOT), Western Blotting, and Radioimmunoassay], biochemistry/clinical chemistry [metabolic panels, electrolyte panels, liver panels, lipid profiles, renal profiles, and thyroid function panels], whole blood glucose monitoring, microbiology, hematology, coagulation & hemostasis, urinalysis, and other technologies), application (infectious diseases [influenza, COVID-19, and gastrointestinal infections], cardiology, oncology, cardiology, diabetes, autoimmune disorders, nephrology, and other applications), diagnostic approach (lab testing, OTC/Self-testing, and point-of-care testing), end user (hospitals & clinics, diagnostic laboratories, home care, and other end users), and geography. The study also evaluates industry competitors and analyzes the market at the country level.
Based on offering, the South East Asia IVD market is segmented into reagents & kits, instruments/systems, software & services. In 2024, the reagents & kits segment is expected to account for the largest share of the market. This large share can be attributed to the recurrent use of reagents and kits, high prevalence of infectious & chronic diseases, and the availability of kits for a wide range of diseases.
Based on technology, the South East Asia IVD market is segmented into molecular diagnostics, immunoassay/immunochemistry, biochemistry/clinical chemistry, whole blood glucose monitoring, hematology, microbiology, coagulation & hemostasis, urinalysis, and other technologies. The molecular diagnostics segment is expected to grow at the highest CAGR during the forecast period. Factors contributing to the segment’s growth are the growing demand for precise infectious disease testing as the region is the hotspot of emerging infectious diseases and the growing prevalence of chronic diseases. Molecular diagnostics enable precise testing of infections and diseases as infectious diseases are hard to diagnose in the initial phase of infections the molecular diagnostics.
Based on application, the South East Asia IVD market is segmented into infectious diseases, oncology, cardiology, diabetes, autoimmune disorders, nephrology, and other applications. In 2024, the infectious disease segment is expected to account for the largest share of the market. This large share is attributed to the increasing number of new cases of infectious diseases, the high risk of emerging infectious diseases for the region, and the initiatives of organizations such as the WHO to monitor and increase awareness. The number of new cases of various infectious diseases continues to rise in the countries of South East Asia region. For instance, in June 2024, a total of 10,335 dengue cases were reported in Thailand, which was 2.5 times higher in May.
Based on diagnostic approach, the South East IVD market is segmented into lab testing, OTC/self-testing, and point-of-care testing. In 2024, the lab testing segment is expected to account for the largest share of the market. This large share is attributed to the hospitals' high preference for diagnostic labs and the capacity of labs to process large samples with lower turnaround times.
Based on end user, the South East Asia IVD market is segmented into diagnostic laboratories, hospitals & clinics, home care, and other end users. The diagnostic laboratories segment is estimated to account for the largest share of the South East Asia IVD market in 2024. The large share of this segment is attributed to the high burden of chronic diseases, the high prevalence of infectious diseases, and large preference for diagnostic laboratories.
Geographic Review:
This research report analyzes major countries and provides a comprehensive analysis of the South East Asia IVD market in Indonesia, Vietnam, Thailand, the Philippines, Malaysia, Singapore, and the Rest of South East Asia. Indonesia is expected to dominate the South East Asia IVD market in 2024. The high prevalence of infectious & chronic diseases, growing healthcare spending, favorable initiatives, and the growing awareness regarding early disease diagnosis are expected to support Indonesia’s largest share.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5613
Key Questions Answered in the Report-
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
IVD Assay Development Market to be Worth $8.39 Billion by 2031
Read MoreNeurogenomics Market to Reach $4.68 Billion by 2031
Read MoreIndia VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market to Reach $7.09 Billion by 2031
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More